As­traZeneca lift

Daily Express - - CITY&BUSINESS -

DRUGS gi­ant As­traZeneca said third-quar­ter net prof­its rose 29 per cent to $1.73bil­lion (£1.03bil­lion) as strong sales in emerg­ing mar­kets such as China helped off­set flat de­mand in the U.S. The com­pany is on the look­out for ac­qui­si­tions.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.